Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kairos Pharma Ltd.

    AMEX: KAPA · Real-Time Price · USD
    0.51
    -0.06 (-10.53%)
    At close: Jun 13, 2025, 3:59 PM
    0.52
    1.72%
    After-hours: Jun 13, 2025, 07:58 PM EDT

    Kairos Pharma Statistics

    Share Statistics

    Kairos Pharma has 16.85M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 16.85M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 9,932

    FTD / Avg. Volume

    n/a
    		 1.45%

    Short Selling Information

    The latest short interest is 19.41K, so 0.12% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 19.41K

    Short % of Shares Out

    n/a
    		 0.12%

    Short % of Float

    n/a
    		 0.19%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -6.63 and the forward PE ratio is -1.44. Kairos Pharma's PEG ratio is -0.19.

    PE Ratio

    n/a
    		 -6.63

    Forward PE

    n/a
    		 -1.44

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 3.61

    P/FCF Ratio

    n/a
    		 -4.36

    PEG Ratio

    n/a
    		 -0.19
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Kairos Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.2, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 4.2

    Quick Ratio

    n/a
    		 4.2

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,603,000

    Employee Count

    n/a
    		 1

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 1.18, so Kairos Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.18

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.74

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 42.73

    Average Volume (20 Days)

    n/a
    		 686,439

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -2.34M

    Net Income

    n/a
    		 -2.6M

    EBITDA

    n/a
    		 -2.34M

    EBIT

    n/a
    		 -2.64M

    Earnings Per Share (EPS)

    n/a
    		 -0.23
    Full Income Statement

    Balance Sheet

    The company has 1.27M in cash and 0 in debt, giving a net cash position of 1.27M.

    Cash & Cash Equivalents

    n/a
    		 1.27M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -8.81M

    Total Assets

    n/a
    		 7.94M

    Working Capital

    n/a
    		 5.25M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -3.96M and capital expenditures 0, giving a free cash flow of -3.96M.

    Operating Cash Flow

    n/a
    		 -3.96M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -3.96M

    FCF Per Share

    n/a
    		 -0.35
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    KAPA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for KAPA is $9, which is 1664.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9

    Price Target Difference

    n/a
    		 1664.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 4.46

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist